ABSTRACT

Manifestations of atherosclerosis are already the leading cause of death in most developed countries.1 Furthermore, it is predicted that ischaemic heart disease will rapidly impose the major global public health burden2 because of its epidemicity in developing countries related to epidemiological transitions associated with urbanization and globalization.3